These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 31691619

  • 1. Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting in vivo.
    Nie H, Qiu B, Yang QX, Zhao Y, Liu XM, Zhang YT, Liao FL, Zhang SY.
    J Liposome Res; 2021 Mar; 31(1):79-89. PubMed ID: 31691619
    [Abstract] [Full Text] [Related]

  • 2. Effect of hydrophile-lipophile balance of the linker in Gal/GalNAc ligands on high-affinity binding of galactosylated liposomes by the asialoglycoprotein receptor.
    Nie H, Liu XM, Yang QX, Luo XD, Zhao Y, Zhang SY.
    Int J Pharm; 2022 Aug 25; 624():121967. PubMed ID: 35777585
    [Abstract] [Full Text] [Related]

  • 3. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C, Kawakami S, Yamashita F, Hashida M.
    J Pharm Sci; 2005 Oct 25; 94(10):2266-75. PubMed ID: 16136555
    [Abstract] [Full Text] [Related]

  • 4. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
    Ishida E, Managit C, Kawakami S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2004 Jun 25; 21(6):932-9. PubMed ID: 15212156
    [Abstract] [Full Text] [Related]

  • 5. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X, Han M, Xu J, Geng S, Zhang Y, Ye X, Gou J, Yin T, He H, Tang X.
    Int J Pharm; 2017 Mar 30; 520(1-2):98-110. PubMed ID: 28167263
    [Abstract] [Full Text] [Related]

  • 6. Novel Galactosylated Poly(ethylene glycol)-Cholesterol for Liposomes as a Drug Carrier for Hepatocyte-Targeting.
    Zhang H, Xiao Y, Cui S, Zhou Y, Zeng K, Yan M, Zhao C.
    J Nanosci Nanotechnol; 2015 Jun 30; 15(6):4058-69. PubMed ID: 26369013
    [Abstract] [Full Text] [Related]

  • 7. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs.
    Kawakami S, Munakata C, Fumoto S, Yamashita F, Hashida M.
    J Pharm Sci; 2001 Feb 30; 90(2):105-13. PubMed ID: 11169527
    [Abstract] [Full Text] [Related]

  • 8. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.
    Murao A, Nishikawa M, Managit C, Wong J, Kawakami S, Yamashita F, Hashida M.
    Pharm Res; 2002 Dec 30; 19(12):1808-14. PubMed ID: 12523658
    [Abstract] [Full Text] [Related]

  • 9. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice.
    Kawakami S, Wong J, Sato A, Hattori Y, Yamashita F, Hashida M.
    Biochim Biophys Acta; 2000 Dec 15; 1524(2-3):258-65. PubMed ID: 11113576
    [Abstract] [Full Text] [Related]

  • 10. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s.
    Shimada K, Kamps JA, Regts J, Ikeda K, Shiozawa T, Hirota S, Scherphof GL.
    Biochim Biophys Acta; 1997 Jun 12; 1326(2):329-41. PubMed ID: 9218563
    [Abstract] [Full Text] [Related]

  • 11. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
    Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2000 Mar 12; 17(3):306-13. PubMed ID: 10801219
    [Abstract] [Full Text] [Related]

  • 12. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting.
    Hattori Y, Kawakami S, Yamashita F, Hashida M.
    J Control Release; 2000 Dec 03; 69(3):369-77. PubMed ID: 11102677
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
    Bernardes GJ, Kikkeri R, Maglinao M, Laurino P, Collot M, Hong SY, Lepenies B, Seeberger PH.
    Org Biomol Chem; 2010 Nov 07; 8(21):4987-96. PubMed ID: 20820666
    [Abstract] [Full Text] [Related]

  • 14. Design and Synthesis of Galactose-Biotin Lipid Materials for Liposomes to Promote the Hepatoma Cell-Targeting Effect.
    Ding R, Li Z, Wang J, Zhu X, Zhao Z, Wang M.
    J Pharm Sci; 2019 Sep 07; 108(9):3074-3081. PubMed ID: 30981753
    [Abstract] [Full Text] [Related]

  • 15. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
    Kawakami S, Yamashita F, Nishikawa M, Takakura Y, Hashida M.
    Biochem Biophys Res Commun; 1998 Nov 09; 252(1):78-83. PubMed ID: 9813149
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin.
    Wang SN, Deng YH, Xu H, Wu HB, Qiu YK, Chen DW.
    Eur J Pharm Biopharm; 2006 Jan 09; 62(1):32-8. PubMed ID: 16226883
    [Abstract] [Full Text] [Related]

  • 17. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo.
    Rensen PC, Sliedregt LA, Ferns M, Kieviet E, van Rossenberg SM, van Leeuwen SH, van Berkel TJ, Biessen EA.
    J Biol Chem; 2001 Oct 05; 276(40):37577-84. PubMed ID: 11479285
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and tissue distribution of docetaxel liposome mediated by a novel galactosylated cholesterol derivatives synthesized by lipase-catalyzed esterification in non-aqueous phase.
    Luo LH, Zheng PJ, Nie H, Chen YC, Tong D, Chen J, Cheng Y.
    Drug Deliv; 2016 May 05; 23(4):1282-90. PubMed ID: 25417833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.